A
Aytu BioPharma, Inc. (AYTU)
NCM – Real Time Price. Currency in USD
2.17
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
2.17
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.17
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
2.17
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $26.7M significantly exceed its total debt $22.9M, ensuring strong financial flexibility
Total current assets $67.3M exceed Total current liabilities $60.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.7) is well below the industry average (-0.8), showcasing prudent financial management
Interest coverage ratio (-9.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.12 | 2.52 | 7.0 | |
| Quick ratio | 1.00 | 1.78 | 6.0 | |
| Debt to Equity | 0.65 | -0.80 | 7.0 | |
| Debt to Assets | 0.21 | 0.73 | 8.0 | |
| Interest coverage | -9.32 | -13.90 | 1.0 | |
| Weighted average score | 5.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 97M | 107M | 65M | 66M | 57M |
| Gross Profit | 46M | 62M | 45M | 42M | 34M |
| Operating Income | -38M | -12M | 565K | 3M | -7M |
| Net Income | -109M | -17M | -16M | -14M | -34M |
| EBITDA | -28M | -4M | 7M | 8M | -3M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -18.89 | 90.1 | 5.5 |
| Next quarter | 23.68 | 87.5 | 10 |
| Current year | -19.03 | 53.1 | 5.5 |
| Next year | 31.41 | 92.45 | 10 |
| Weighted average score | 7.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -18.15 | 46.92 | 49.52 | -214.31 | 5.5 |
| Y/Y | -32.73 | -240.65 | -364.99 | 35.9 | 3.3 |
| 3y average | -8.78 | 35.27 | 52.73 | 40.97 | 7.8 |
| 5y average | 31.69 | -61.73 | 26.89 | 24.08 | 7.8 |
| Weighted average score | 6.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |